Effect of Pulsed Electromagnetic Field on Pruritus in Burn Scars

ConditionBurn Scar

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age25-40

SponsorCairo University

About this trial

This study will be conducted to evaluate the effectiveness of pulsed electromagnetic field therapy in pruritus in patients with burn scars.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients aged 25-40 years.

Patients with second and third-degree burn scars sustained at least 3 months prior to enrollment.

Patients experiencing a pruritus score ≥ 5 on the Visual Analog Scale (VAS).

Patients who have not undergone prior PEMF therapy or other physical therapy interventions for pruritus in the past 3 months.

Disqualifiers

Patients with cardiac pacemakers, implanted defibrillators, or other electronic medical devices.

Pregnant or lactating women.

Patients with uncontrolled systemic diseases (e.g., diabetes, hypertension) or active skin infections.

Patients with psychological disorders that would interfere with their ability to adhere to the treatment protocol.

Trial design

Design model

Parallel

Treatments tested in this trial

pulsed electromagnetic field therapy
Other intervention
The pulsed electromagnetic field applicator will be positioned 2 cm above the affected burn scar area, ensuring full coverage of the scar with Frequency: 27.12 MHz, Pulse duration: 65 microseconds, and Intensity: 20 Gauss. the patients will receive also standard care
standard care
Other intervention
the patients will receive standard care in the form of Application of topical emollients (e.g., silicone-based creams) twice daily to maintain hydration, Moisturizing skin care routines to prevent dryness and irritation, and Gentle scar massage for 10 minutes daily to improve scar pliability.

Treatment groups

40 Participants

are divided into 2 treatment groups

Group A: pulsed electromagnetic field therapyExperimental treatment 2 interventions

Group B: standard careActive comparator 1 intervention

Trial outcomes

Primary outcomes

pain intensity

The Visual Analog Scale (VAS) will be used to measure the intensity of pruritus experienced by participants. The scale consists of a 10 cm horizontal line where 0 cm represents "No itch at all," and 10 cm represents "The worst itch imaginable." Participants will be asked to place a vertical mark on the line corresponding to the severity of their pruritus. The distance from the left end of the scale to the mark, measured in centimeters, will represent the participant's itching score, ranging from 0 to 10.

Time frame

up to 6 weeks

life disability

The ItchyQoL questionnaire will evaluate the impact of pruritus on participants' quality of life across three domains: symptoms, functional limitations, and emotional well-being. It is a 22-item self-administered tool scored on a 5-point Likert scale, with responses ranging from 1 (Not at all) to 5 (Extremely). Higher scores indicate a greater negative impact of itch on quality of life, with total scores ranging from 22 to 110. Subdomain scores will also be calculated to provide a detailed analysis of how itch affects daily activities and emotional well-being.The assessment time for completing the ItchyQoL is typically 5-10 minutes, depending on the patient's literacy level and familiarity with self-reported questionnaires.

Time frame

up to 6 weeks

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Cairo University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: